"Global Artificial Intelligence (AI) In Pharmaceutical Market Overview:
Global Artificial Intelligence (AI) In Pharmaceutical Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Artificial Intelligence (AI) In Pharmaceutical Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Artificial Intelligence (AI) In Pharmaceutical involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Artificial Intelligence (AI) In Pharmaceutical Market:
The Artificial Intelligence (AI) In Pharmaceutical Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Artificial Intelligence (AI) In Pharmaceutical Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Artificial Intelligence (AI) In Pharmaceutical Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Artificial Intelligence (AI) In Pharmaceutical market has been segmented into:
AI
By Application, Artificial Intelligence (AI) In Pharmaceutical market has been segmented into:
Cloud and On-Premise
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Artificial Intelligence (AI) In Pharmaceutical market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Artificial Intelligence (AI) In Pharmaceutical market.
Top Key Players Covered in Artificial Intelligence (AI) In Pharmaceutical market are:
NVIDIA Corporation
IBM Corporation
Exscientia
Insilico Medicine
Atomwise
Inc.
Cloud Pharmaceuticals
Inc.
Cyclica Inc.
Envisagenics
Inc.
Numerate
Inc.
Schrödinger
Inc.
Standigm
Turbine.ai
BenevolentAI
Recursion Pharmaceuticals
Owkin
Inc.
XtalPi Inc.
Valo Health
Absci
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Artificial Intelligence (AI) In Pharmaceutical Market by Type
4.1 Artificial Intelligence (AI) In Pharmaceutical Market Snapshot and Growth Engine
4.2 Artificial Intelligence (AI) In Pharmaceutical Market Overview
4.3 AI
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 AI: Geographic Segmentation Analysis
Chapter 5: Artificial Intelligence (AI) In Pharmaceutical Market by Application
5.1 Artificial Intelligence (AI) In Pharmaceutical Market Snapshot and Growth Engine
5.2 Artificial Intelligence (AI) In Pharmaceutical Market Overview
5.3 Cloud and On-Premise
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cloud and On-Premise: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Artificial Intelligence (AI) In Pharmaceutical Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 NVIDIA CORPORATION
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 IBM CORPORATION
6.4 EXSCIENTIA
6.5 INSILICO MEDICINE
6.6 ATOMWISE
6.7 INC.
6.8 CLOUD PHARMACEUTICALS
6.9 INC.
6.10 CYCLICA INC.
6.11 ENVISAGENICS
6.12 INC.
6.13 NUMERATE
6.14 INC.
6.15 SCHRÖDINGER
6.16 INC.
6.17 STANDIGM
6.18 TURBINE.AI
6.19 BENEVOLENTAI
6.20 RECURSION PHARMACEUTICALS
6.21 OWKIN
6.22 INC.
6.23 XTALPI INC.
6.24 VALO HEALTH
6.25 ABSCI
Chapter 7: Global Artificial Intelligence (AI) In Pharmaceutical Market By Region
7.1 Overview
7.2. North America Artificial Intelligence (AI) In Pharmaceutical Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 AI
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Cloud and On-Premise
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Artificial Intelligence (AI) In Pharmaceutical Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 AI
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Cloud and On-Premise
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Artificial Intelligence (AI) In Pharmaceutical Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 AI
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Cloud and On-Premise
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Artificial Intelligence (AI) In Pharmaceutical Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 AI
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Cloud and On-Premise
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Artificial Intelligence (AI) In Pharmaceutical Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 AI
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Cloud and On-Premise
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Artificial Intelligence (AI) In Pharmaceutical Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 AI
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Cloud and On-Premise
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Artificial Intelligence (AI) In Pharmaceutical Scope:
|
Report Data
|
Artificial Intelligence (AI) In Pharmaceutical Market
|
|
Artificial Intelligence (AI) In Pharmaceutical Market Size in 2025
|
USD XX million
|
|
Artificial Intelligence (AI) In Pharmaceutical CAGR 2025 - 2032
|
XX%
|
|
Artificial Intelligence (AI) In Pharmaceutical Base Year
|
2024
|
|
Artificial Intelligence (AI) In Pharmaceutical Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
NVIDIA Corporation, IBM Corporation, Exscientia, Insilico Medicine, Atomwise, Inc., Cloud Pharmaceuticals, Inc., Cyclica Inc., Envisagenics, Inc., Numerate, Inc., Schrödinger, Inc., Standigm, Turbine.ai, BenevolentAI, Recursion Pharmaceuticals, Owkin, Inc., XtalPi Inc., Valo Health, Absci.
|
|
Key Segments
|
By Type
AI
By Applications
Cloud and On-Premise
|
